American Heart Journal
Volume 156, Issue 6 , Pages 1155-1162.e2 , December 2008

Genetic variation at the 9p21 locus predicts angiographic coronary artery disease prevalence but not extent and has clinical utility

  • Jeffrey L. Anderson, MD, FACC

      Affiliations

    • Cardiovascular Department, Intermountain Medical Center, Murray, UT
    • Cardiology Division, University of Utah School of Medicine, Salt Lake City, UT
    • Corresponding Author InformationReprint requests: Jeffrey L. Anderson, MD, Cardiovascular Department, Intermountain Medical Center, 5121 S. Cottonwood Street, Murray, UT 84107.
    • ,
  • Benjamin D. Horne, PhD, MPH

      Affiliations

    • Cardiovascular Department, Intermountain Medical Center, Murray, UT
    • Genetic Epidemiology Division, University of Utah School of Medicine, Salt Lake City, UT
    • ,
  • Matthew J. Kolek, MD

      Affiliations

    • Cardiovascular Department, Intermountain Medical Center, Murray, UT
    • ,
  • Joseph B. Muhlestein, MD, FACC

      Affiliations

    • Cardiovascular Department, Intermountain Medical Center, Murray, UT
    • Cardiology Division, University of Utah School of Medicine, Salt Lake City, UT
    • ,
  • Chrissa P. Mower, BS

      Affiliations

    • Cardiovascular Department, Intermountain Medical Center, Murray, UT
    • ,
  • James J. Park, BS

      Affiliations

    • Cardiovascular Department, Intermountain Medical Center, Murray, UT
    • ,
  • Heidi T. May, MSPH

      Affiliations

    • Cardiovascular Department, Intermountain Medical Center, Murray, UT
    • Cardiology Division, University of Utah School of Medicine, Salt Lake City, UT
    • ,
  • Nicola J. Camp, PhD

      Affiliations

    • Genetic Epidemiology Division, University of Utah School of Medicine, Salt Lake City, UT
    • ,
  • John F. Carlquist, PhD

      Affiliations

    • Cardiovascular Department, Intermountain Medical Center, Murray, UT
    • Cardiology Division, University of Utah School of Medicine, Salt Lake City, UT

Received 13 June 2008 ,Accepted 10 July 2008.

References 

  1. Rosamond W, Flegal K, Friday G, et al. Heart disease and stroke statistics–2007 update: a report from the American Heart Association Statistics Committee and the Stroke Statistics Subcommittee. Circulation. 2007;115:69–171
  2. Yusuf S, Reddy S, Ôunpuu S, et al. Global burden of cardiovascular diseases, part I: general considerations, the epidemiologic transition, risk factors, and impact of urbanization. Circulation. 2001;104:2746–2753
  3. Yusuf S, Hawken S, Ounpuu S, et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet. 2004;364:934–952
  4. Williams RR, Hunt SC, Heiss G, et al. Usefulness of cardiovascular family history data for population-based preventive medicine and medical research (the Health Family Tree Study and the NHLBI Family Heart Study). Am J Cardiol. 2001;87:129–135
  5. Marenberg ME, Risch N, Berkman LF, et al. Genetic susceptibility to death from coronary heart disease in a study of twins. N Engl J Med. 1994;330:1041–1046
  6. Zdravkovic L, Wienke A, Pedersen NL, et al. Heritability of death from coronary heart disease: a 36-year follow-up of 20 966 Swedish twins. J Intern Med. 2002;252:247–254
  7. Wienke A, Holm NV, Skytthe A, et al. The heritability of mortality due to heart diseases: a correlated frailty model applied to Danish twins. Twin Res. 2001;4:266–274
  8. Hopkins PN, Hunt SC, Wu LL. Family history and genetic factors. In:  Wong ND,  Black HR,  Gardin JM editor. Preventive cardiology, a practical approach. New York: McGraw-Hill; 2005;p. 92–148
  9. Topol EJ, Smith J, Plow EF, et al. Genetic susceptibility to myocardial infarction and coronary artery disease. Hum Molec Genet. 2006;15:R117–R123
  10. Anderson JL, Carlquist JF, Horne BD, et al. Progress in unraveling the genetics of coronary artery disease and myocardial infarction. Curr Atheroscl Rep. 2007;9:179–186
  11. Ioannidis JPA, Ntzani EE, Trikalinos TA, et al. Replication validity of genetic association studies. Nat Genet. 2001;29:306–309
  12. Hegele RA. SNP judgments and freedom of association. Arterioscler Thromb Vasc Biol. 2002;22:1058–1061
  13. Morgan TM, Krumholz HM, Lifton RP, et al. Nonvalidation of reported genetic risk factors for acute coronary syndrome in a large-scale replication study. JAMA. 2007;297:1551–1561
  14. Yamada YH, Izawa H, Ichihara S, et al. Prediction of the risk of myocardial infarction from polymorphisms in candidate genes. N Engl J Med. 2002;347:1916–1923
  15. Chanock SJ, Manolio T, Boehnke M, et al. Replicating genotype-phenotype associations. Nature. 2007;447:655–660
  16. Christensen K, Murray JC. What genome-wide association studies can do for medicine. N Engl J Med. 2007;356:1094–1097
  17. Topol EJ, Murray SS, Frazer KA. The genomics gold rush. JAMA. 2007;298:218–221
  18. Wellcome Trust Case-Control Consortium . Genome-wide association study of 14,000 cases of seven common disease and 3,000 shared controls. Nature. 2007;447:661–678
  19. McPherson R, Pertsemlidis A, Kavaslav N, et al. A common allele on chromosome 9 associated with coronary heart disease. Science. 2007;316:1488–1491
  20. Helgadottir A, Thorleifsson G, Manolescu A, et al. A common variant on chromosome 9p21 affects the risk of myocardial infarction. Science. 2007;316:91–93
  21. Samani NJ, Erdmann J, Hall AS, et al. Genomewide association analysis of coronary artery disease. N Engl J Med. 2007;357:443–453
  22. Larson MG, Atwood LD, Benjamin EJ, et al. Framingham Heart Study 100K project: genome-wide associations for cardiovascular disease outcomes. BMC Med Genet. 2007;8(Suppl I: S5):1–9
  23. Broadbent HM, Peden JF, Lorkowski S, et al. Susceptibility to coronary artery disease and diabetes is encoded by distinct, tightly linked SNPs in the ANRIL locus on chromosome 9p. Hum Mol Genet. 2008;17:806–814
  24. Shen G-Q, Shen LL, Rao S, et al. Four SNPs on chromosome 9p21 in a South Korean population implicate a genetic locus that confers high cross-race risk for development of coronary artery disease. Arterioscler Thromb Vasc Biol. 2008;28:360–365
  25. Shen G-Q, Rao S, Martinelli N, et al. Association between four SNPs on chromosome 9p21 and myocardial infarction is replicated in an Italian population. J Hum Genet. 2008;53:144–150
  26. Smith LR, Harrell FEJ, Rankin JS, et al. Determinants of early versus late cardiac death in patients undergoing coronary artery bypass graft surgery. Circulation. 1991;84(Suppl 5):III245–III253
  27. Horne BD, Camp NJ, Carlquist JF, et al. Multiple-polymorphism associations of seven matrix metalloproteinase and tissue inhibitor metalloproteinase genes with myocardial infarction and angiographic coronary artery disease. Am Heart J. 2007;154:751–758
  28. Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation. 2002;106:3143–3421
  29. Allen-Brady K, Wong J, Camp NJ. PedGenie: an analysis approach for genetic association testing in extended pedigrees and genealogies of arbitrary size. BMC Bioinformatics. 2006;7:209–220
  30. Pearson TA, Mensah G, Alexander W, et al. Markers of inflammation and cardiovascular disease: application to clinical and public health practice. A statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. Circulation. 2003;107:499–511
  31. Schunkert J, Goetz A, Braund P, et al. Repeated replication and a prospective meta-analysis of the association between chromosome 9p21.3 and coronary artery disease. Circulation. 2008;117:1675–1684
  32. Lp-PLA2 Studies Collaboration. Collaborative meta-analysis of individual participant data from observational studies of Lp-PLA2 and cardiovascular diseases. Eur J Cardiovasc Prev Rehabil. 2007;14:3–11
  33. Pencina JJ, D'Agostino RBS, D'Agostino RBJ, et al. Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond. Statist Med. 2008;27:157–172

 The study was funded by grants from the National Institutes of Health, National Heart, Lung, and Blood Institute (R01HL071878) (both in Bethesda, MD), and the Deseret Foundation, Intermountain Healthcare, Salt Lake City, UT.

 This content is solely the responsibility of the authors and does not necessarily represent the official views of the National Heart, Lung, and Blood Institute or the National Institutes of Health.

PII: S0002-8703(08)00616-9

doi: 10.1016/j.ahj.2008.07.006

American Heart Journal
Volume 156, Issue 6 , Pages 1155-1162.e2 , December 2008

Article Tools

* Image Usage & Resolution